Scheduled presentations:

• Keynote How to make clinical predictions when we do not know everything?
  *H. Hatzikirou (Khalifa University)
• Mathematical Modelling of in vitro Glioblastoma Adaptation to Evaluate its Response to Chemotherapy with Temozolomide.
  *M. Pérez-Aliacar (Aragón Institute of Engineering Research), J. Ayensa-Jiménez (Aragón Institute of Engineering Research), M. Doblaré (Aragón Institute of Engineering Research)
• Evolution of Phenotypic Plasticity Leads to Tumor Heterogeneity with Implications for Therapy
  *S. Syga (Dresden University of Technology), H. Hatzikirou (Khalifa University), A. Deutsch (Dresden University of Technology)
• Integrating Cell Cycle Data from In Vitro and In Silico Models to Target Radiation Response and Cancer Resistance After Radiation Exposure
  *L. Lonati (Radiobiology and Biophysics of Radiation Grou), I. Guardamagna (Radiobiology and Biophysics of Radiation Grou), O. Iaria (Radiobiology and Biophysics of Radiation Grou), A. Mentana (Radiobiology and Biophysics of Radiation Grou), A. Previtalia (Unit of Immunology and General Pathology, Dep), G. Baiocco (Radiobiology and Biophysics of Radiation Grou)
• Modelling the Influence of Loss of E-Catherin and Stroma Attachment in Cancer Cell Invasion: Mathematic Approach
  *P. guerrero (Universidad Carlos III de Madrid)